Stock Price
0.63
Daily Change
0.05 8.70%
Monthly
-3.85%
Yearly
52.44%
Q2 Forecast
0.61

Somnomed reported AUD19.5M in Selling and Administration Expenses for its fiscal semester ending in June of 2023.





Selling And Administration Expenses Change Date
Alcidion AUD 1.09M 184K Dec/2025
Cochlear AUD 449.4M 214.45M Dec/2025
Fisher & Paykel Healthcare NZD 285.5M 11.6M Dec/2025
Nanosonics AUD 53.78M 26.93M Dec/2025
Polynovo AUD 17.04M 1.91M Dec/2025
ResMed USD 275.7M 16.51M Dec/2025